Epidemiology of Parkinson’s Disease Julián Benito-León, MD, PhD Department of Neurology University Hospital “12 de Octubre” Madrid, Spain.

Slides:



Advertisements
Similar presentations
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Advertisements

Case-Control Studies (Retrospective Studies). What is a cohort?
Wisconsin HIV/AIDS Surveillance Annual Review: Slide Set New diagnoses, prevalent cases, and deaths through December 2014 April 2015 P Wisconsin.
Virginia Rodriguez Funes, MD, FACS El Salvador. Background  The Latin American population it is now the largest single ethnic group in the United States,
Lec. 1 Dr. Abdullah K. Rabba Ph.D
4.6 Assessment of Evaluation and Treatment 2013 Analytic Lung Cancer.
Breast Cancer Risk and Risk Assessment Models
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
Meredith G. Hennon, MPH and the Supercourse team in Pittsburgh.
Every Woman, Every Time: Disparities in Breast Cancer Tony L. Weaver, D.O. ALOMA 2015.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
Epidemiology of Stroke Dexter L. Morris, PhD, MD Department of Emergency Medicine University of North Carolina School of Medicine Chapel Hill, NC.
World Burden of Cancer Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
 Psychological disturbances came from irrational and illogical thinking.  Irrational beliefs such as “I must get 100% in every test” etc and “I didn’t.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Caring for Children With Special Medical Conditions
DAREDEVILS: Prajwal Acharya, Cristina Johnson, Julie David, Jen Masciovecchio, Yen Phan.
A Summary Of Key Findings From A National Survey Of Voters. #07160.
The Nature of Disease.
1 Causation in Epidemiological Studies Dr. Birgit Greiner Senior Lecturer.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Peritoneal Dialysis for Elderly Patients: A Review Source: Tesar V. Peritoneal dialysis in the elderly—is its underutilization justified? Nephrol Dial.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
Initial presentation of multiple sclerosis in northern Iran; Is there any comparison to other countries Initial presentation of multiple sclerosis in northern.
Epidemiology of Parkinson’s Disease
Otis W. Brawley M.D. Director, Georgia Cancer Center Associate Director, Winship Cancer Institute Professor of Hematology, Oncology, and Epidemiology Emory.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Why are White Nursing Home Residents Twice as Likely as African Americans to Have an Advance Directive? Understanding Ethnic Differences in Advance Care.
MS: A Perspective on the African American Experience Mary D. Hughes, MD Medical Director, Neuroscience Associates University Medical Group Greenville Hospital.
Metabolic Syndrome and Recurrence within the 21-Gene Recurrence Score Assay Risk Categories in Lymph Node Negative Breast Cancer Lakhani A et al. Proc.
CHAPTER 23: Neurological Disorders in Women. Introduction Gender differences exist in the development and expression of several neurological disorders,
Health Disparities and Multicultural Practice Clarence H. Braddock III, MD, MPH, FACP Associate Professor of Medicine Associate Dean, Medical Education.
“The African American Prostate Cancer Crisis in Numbers”
Module 2 - Epidemiology of Tuberculosis
Lecture 7 Objective 18. Describe the elements of design of observational studies: case ‑ control studies (retrospective studies). Discuss the advantages.
Nies and Nies and McEwen: Chapter 4: ATI: Chapter 3 Epidemiology.
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
ACT on Alzheimer’s Disease Curriculum Module II: Demographics.
Epidemiology of Alzheimer’s Disease
University Hospitals Portage Medical Center. Portage County has one of the highest annual incidence rates of bladder cancer in the state of Ohio. According.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
+ Child & Adolescent Psychology Welcome to Seminar #9.
Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung function Tang, W; et al. (2013) Catherine Arcangelo, Hailee.
Analytical Studies Case – Control Studies By Dr. Sameh Zaytoun (MBBch, DPH, DM, FRCP(Manch), DTM&H(UK),Dr.PH) University of Alexandria - Egypt Consultant.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
ALDH2 and Conduct Disorder Mediate Ethnicity and Alcohol Dependence in Chinese-, Korean-, and White-American College Students S.E. Luczak, T.A.R. Cook,
Pathogenesis and pathology of parkinsonism
Copyright © 2016 The McGraw-Hill Companies, Inc. Permission required for reproduction or display. D ESIGN OF E XPERIMENTS Section 1.3.
Taina K. Lajunen, Jouni J. K. Jaakkola, and Maritta S. Jaakkola Am J Respir Crit Care Med Vol 188, Issue 7, Oct 1, 2013 호흡기내과 R2 김다래 / 장나은선생님.
Improvements needed in the care of people living with Dementia.
DIAGNOSIS OF WILSON’S DISEASE – A 20-YEAR AUDIT Geetha Rathnayake 1, Mirette Saad 2, Kay Weng Choy 1, James CG Doery 1,3 1 Monash Pathology, Monash Medical.
©2012 Cengage Learning. All Rights Reserved. Chapter 4 Common Chronic Medical Conditions Affecting Children’s Health.
Prostate cancer and ethnicity Luke Hounsome Public Health England ‘Hear me now’ workshop - Birmingham.
Instructional Objectives:
Schizophrenia: an inside view
Epidemiology: Assignment 3
Changing demographics and the impact on dementia
Presentation for the SCTR Scientific Retreat on Aging Related Research
Prostate cancer and ethnicity Luke Hounsome Public Health England
Geographic Pattern of Type 1 Diabetes Mellitus in Children in Central Ohio: Higher risk of New Cases in Rural and Urban Areas. Sasigarn A. Bowden, MD,
It is estimated that almost 1
Alzheimer's.
It is estimated that more than 1
Prepared by staff in Prevention and Cancer Control.
ACT on Alzheimer’s Disease Curriculum
Presentation transcript:

Epidemiology of Parkinson’s Disease Julián Benito-León, MD, PhD Department of Neurology University Hospital “12 de Octubre” Madrid, Spain

Importance of Epidemiology Health care and planning Tool for investigation of the etiology and risk factors for PD Defining disease characteristics such as prevalence, incidence, and mortality

Origins of Parkinson’s Parkinson's disease was first formally described in "An Essay on the Shaking Palsy," published in 1817 by a London physician named James Parkinson It has probably existed for many thousands of years

Origins of Parkinson’s Symptoms and potential therapies mentioned in: Ayurveda, the system of medicine practiced in India as early as 5000 BC First Chinese medical text, Nei Jing, which appeared 2500 years ago

Prevalence How many people have PD? Estimated 1 million patients in US Second most common age-related neurodegenerative disorder Second in frequency only to Alzheimer’s disease

Prevalence How many people have PD? World-wide estimates vary 15/100,000 in China 657/100,000 in Argentina /100,000 in North America and Europe The prevalence figures of PD in Africa appeared lower than those reported for European and North American populations.

PD compared to other neurological diseases (Neurological Disorders in Central Spain) Fuente: Díaz-Guzmán J, Bermejo-Pareja F, Benito-León, J, et al. Neuroepidemiology (en evaluación). Fuente: Benito-León, J, Bermejo-Pareja F, Rodríguez J, et al. Mov Disord 2003;18: Fuente: Bermejo-Pareja F, Benito-León, Vega S, et al. Neuroepidemiology (en evaluación). Fuente: Benito-León, J, Bermejo-Pareja F, Morales JM, et al. Mov Disord 2003;18: Prevalence: – Dementia: 5.8% (95% IC ) – Essential tremor: 4.8% (95% IC ) – Stroke: 3.5% (95% IC ) – TIA: 1.3% (95% IC ) – Parkinsonism: 2.2% (95% IC, ) – Parkinson’s disease: 1.5% (95% IC, )

Incidence Quantifies the number of individuals who are newly diagnosed with PD in a given time period Unaffected by factors affecting disease survival

Incidence Quantifies the number of individuals who are newly diagnosed with PD in a given time period Unaffected by factors affecting disease survival Accurate measurements of the incidence of PD are relatively difficult Clinical manifestations of PD may be preceded by a long latent stage and have a slow clinical progression

Incidence Difficult to know how many people are diagnosed each year: Symptoms may develop and progress slowly Diagnostic criteria may vary

Incidence China: 1.5/100,000 Finland: 14.8/100,000 US: 20/100,000 Variations may be due to different diagnostic criteria and methods of case ascertainment in studies Lifetime risk of PD: 1 in 40

Incidence

Role of age, gender, and ethnicity

Age The incidence of PD increases with age Symptoms of Parkinson’s disease may appear at any age The median age of onset for idiopathic PD is 62.4 years Onset before age 30 is rare, but up to 10% of cases of idiopathic PD begin by age 40

Age Prevalence and incidence increases with age from age Affects 0.3% of general US population Aging alone does not cause PD May increase susceptibility to other factors or allow them to be expressed

Gender Slightly more common in men than in women Estimated men for every 10 women

Ethnicity Present worldwide, in all populations No region found to be free of PD More common in white people in Europe and North America ( /100,000) Lower rates in China, Nigeria and Sardinia The disorder occurs in all races but is somewhat more prevalent among Caucasians

Ethnicity Generally less common among African- Americans and Asians one-fifth to one-tenth as prevalent as in whites In Africa less common among blacks than whites

Ethnicity Door-to-door screening in Mississippi PD prevalence was not significantly different in whites and blacks after adjusting for age differences (poor diagnostic criteria) Higher prevalence in whites with strict diagnostic criteria

Ethnicity Two other studies conducted PD incidence in African-Americans and in Asian- Americans was similar to rates for European- Americans Door-to-door survey in Taiwan Prevalence of PD =119/100,000 Similar to that of a white population and much higher than that of previous studies of Asian populations

Ethnicity Differences in findings Suggest environmental factors more important than racial factors Further studies needed Other factors? Differences in access to healthcare?

Ethnicity The disease was once thought to affect primarily whites, but recent studies have demonstrated equal prevalence in African Americans and whites living in the same geographic area. Retrospective epidemiologic studies performed in various major cities have yielded contradictory information.

Ethnicity Variations in the prevalence of the disease in individual racial groups in different geographic areas have suggested an increased risk associated with rural living.

Causes The cause of Parkinson’s disease is unknown. Many researchers believe that several factors combined are involved: free radicals, accelerated ageing, environmental toxins, and genetic predisposition.

What Causes Parkinson's? The cause is probably a combination of genetic and environmental factors, and may vary from person to person.

What Causes Parkinson's? Although the cause of Parkinson's remains unknown, scientists have identified factors that contribute to Parkinson's in some patients. – People over age 60 have a two-to-four percent risk of developing Parkinson's disease, compared with the one-to-two percent risk in the general population.

Risk Factors and Protective Factors The single biggest risk factor for PD is advancing age Men have a slightly elevated risk compared to women

Risk Factors and Protective Factors Family history is also an important risk factor Individuals with an affected first-degree relative are estimated to have an approximately doubled risk for developing PD This increase cannot be explained by presence of any of the known genetic causes of PD, which together account for only a small percentage of familial cases

Risk Factors and Protective Factors Caffeine consumption is associated with a reduced incidence of PD Cigarette smoking has been associated with a reduced risk of PD It is not known whether smoking confers a genuine protective effect, or whether individuals who are prone to develop PD for other reasons are also prone to avoid smoking Nonetheless, the negative impact on general health from smoking is enormous, far in excess of any slight reduction in risk for PD Smoking cannot be recommended as a strategy for avoiding PD

Risk Factors Environment Environmental factors may play a role in PD Several members of some families with widely different ages developed PD within a short period of time The vast majority of cases of PD are thought to be due to the potential interactions of genes and the environment

Environmental Factors Factors include: physical trauma, exposure to chemicals and infections, and nutrition

Rural Living A strong and consistent finding is that the risk of PD is increased by: – rural living – exposure to well water – agricultural work Suggests that pesticides and/or herbicides may cause or contribute to PD

Environmental Toxins These conclusions are strengthened by several identified toxins that induce parkinsonism in animal models, and even in humans MPTP - originally identified as a contaminant in a batch of "street heroin" in Berkeley, California in the 1980s – Addicts who injected it developed a clinical syndrome almost identical to PD

Environmental Toxins The identification of MPTP led to much productive work on the cellular pathogenesis of PD However, numerous toxicological studies have demonstrated that MPTP itself is extremely rare in the environment, and thus is not a significant contributor to idiopathic PD It remains to be seen if any single agent will eventually be shown to account for more than a small fraction of PD cases

Genetics and Pathogenesis While the known genes for PD are responsible for only a minority of cases, they have provided extraordinary insight into the molecular pathology of the disease

Genetics Roughly one-fifth of Parkinson's disease patients have at least one relative with parkinsonian symptoms Suggests that a genetic factor may be involved Several genes that cause symptoms in younger patients have been identified Most researchers believe, however, that most cases are not caused by genetic factors alone

Genetics Genetic research studies over the past seven years have uncovered a total of 10 genes associated with PD For most cases of PD, however, these genes are not thought to play a role Small as their role may be, genes provide a crucial opportunity for us to study how the brain works

Genetics Because most patients do not have a clear history of either familial or environmental risk factors, the disorder may be due to a combination of genetic and environmental "influences" or "causes" In a small number of cases worldwide there is a strong inheritance pattern A genetic predisposition for Parkinson’s disease is possible, with the onset of disease and its gradual development dependant on a trigger, such as trauma, other illness, or exposure to an environmental toxin

Genetics In large epidemiological studies, researchers have found that people with an affected first-degree relative, such as a parent or sibling, have a two- to-three fold increased risk of developing Parkinson's, as compared to the general population

Genetics The vast majority of Parkinson's cases are not directly inherited, but researchers have discovered several genes that can cause the disease in a small number of families

Genetics Because genetic forms of a disease can be studied in great detail in the laboratory, and because understanding the rare genetic forms of Parkinson's disease may help to understand more common forms of the disease, genetic aspects of PD are currently the subject of intense research

PD and Genetic Testing Genetic testing in the general PD population - at the current stage of scientific knowledge - is not going to be helpful Researchers are still trying to determine which genetic factors contribute to the development of PD for the average patient

PD and Genetic Testing This is a very challenging task because we suspect that the interaction of genes with each other and with the environment is probably unique to each individual Until we gain this level of knowledge, we are a long way off from being able to offer the public PD genetic testing and accurate risk information for family members

PD Genetics and the Future The recent identification of genes that cause PD in a small group of PD families is helping us to understand the processes that lead to the development of PD Future research will undoubtedly reveal additional PD-associated genes and susceptibility factors, which will help us to further understand the cause of PD and lead to better diagnosis and treatment

Merci beaucoup!